Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.56M | 6,452,398 | 3.42% | 96.58% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $18.94M | 51,456,077 | 9.46% | 11.78% | Net Buying | |||
| IMA | IMAGENEBIO INC | $91.30M | 11,181,672 | 31.34% | 68.66% | Net Buying | |||
| CANF | CAN-FITE BIOPHARMA LTD | $4.40M | 3,967,407,393 | 0.04% | 0.00% | ||||
| ATYR | ATYR PHARMA INC | $73.78M | 97,986,634 | 63.19% | 15.70% | Net Buying | Net Buying | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $35.65M | 21,869,491 | 1.17% | 98.83% | Net Selling | |||
| NRXP | NRX PHARMACEUTICALS INC | $69.96M | 28,097,627 | 7.36% | 92.64% | Net Buying | |||
| SGMO | SANGAMO THERAPEUTICS INC | $149.74M | 336,494,489 | 18.04% | 9.55% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $70.09M | 137,429,055 | 3.79% | 17.25% | Net Buying | Net Buying | ||
| TVRD | TVARDI THERAPEUTICS INC | $37.81M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| GRI | GRI BIO INC | $5.52M | 3,268,727 | 4.11% | 84.15% | ||||
| ACET | ADICET BIO INC | $101.46M | 153,255,581 | 33.07% | 10.89% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $57.16M | 9,417,295 | 24.91% | 75.09% | ||||
| SKYE | SKYE BIOSCIENCE INC | $41.67M | 32,057,461 | 2.67% | 97.33% | Net Selling | Net Selling | ||
| CING | CINGULATE INC | $23.58M | 6,757,070 | 3.76% | 96.24% | ||||
| LSTA | LISATA THERAPEUTICS INC | $18.70M | 8,820,733 | 0.85% | 99.15% | Net Selling | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $13.99M | 10,764,428 | 0.18% | 99.82% | Net Buying | Net Selling | ||
| MTVA | METAVIA INC | $16.93M | 24,214,788 | 1.37% | 98.63% | Net Buying | |||
| VNRX | VOLITIONRX LTD | $40.65M | 122,801,572 | 13.64% | 31.01% | Net Buying | Net Buying | ||
| CYBN | CYBIN INC | $136.59M | 23,033,127 | 36.62% | 0.00% | ||||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.07M | 24,292,833 | 3.72% | 59.15% | ||||
| RNXT | RENOVORX INC | $27.49M | 36,649,916 | 19.37% | 11.42% | Net Buying | Net Buying | ||
| ZYXI | ZYNEX INC | $17.27M | 30,297,442 | 12.79% | 46.80% | Net Selling | |||
| MYO | MYOMO INC | $31.36M | 38,435,524 | 35.30% | 11.05% | Net Selling | Net Buying | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $8.77M | 1,919,441 | 3.86% | 96.14% | Net Buying | |||
| MBRX | MOLECULIN BIOTECH INC | $22.10M | 50,910,476 | 1.53% | 12.52% | Net Buying | Net Selling | ||
| AVXL | ANAVEX LIFE SCIENCES CORP | $313.08M | 85,893,834 | 37.94% | 5.17% | Net Buying | Net Buying | ||
| SLN | SILENCE THERAPEUTICS PLC | $322.29M | 141,701,848 | 11.76% | 0.09% | ||||
| TIL | INSTIL BIO INC | $97.80M | 6,781,976 | 5.64% | 94.36% | Net Buying | Net Buying | ||
| CTSO | CYTOSORBENTS CORP | $41.45M | 62,804,305 | 26.01% | 45.05% | Net Buying | |||
| NAKA | KINDLY MD INC | $4.67M | 7,606,339 | 78.14% | 21.86% | Net Buying | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $10.10M | 1,261,290 | 0.27% | 99.73% | Net Selling | |||
| IMUX | IMMUNIC INC | $93.70M | 120,284,724 | 33.93% | 13.20% | Net Buying | |||
| IFRX | INFLARX NV | $91.46M | 67,747,130 | 27.39% | 0.00% | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $103.34M | 129,171,424 | 14.98% | 11.04% | Net Buying | |||
| HUMA | HUMACYTE INC | $230.34M | 187,271,321 | 24.48% | 16.09% | Net Selling | Net Selling | ||
| JSPR | JASPER THERAPEUTICS INC | $47.01M | 27,984,039 | 27.42% | 72.58% | Net Buying | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $57.76M | 115,058,619 | 8.13% | 9.28% | ||||
| CABA | CABALETTA BIO INC | $222.37M | 96,265,204 | 70.54% | 4.39% | ||||
| BMEA | BIOMEA FUSION INC | $90.50M | 70,703,639 | 35.45% | 24.33% | Net Buying | |||
| AMTX | AEMETIS INC | $125.89M | 65,568,542 | 8.40% | 91.60% | Net Buying | |||
| BNGO | BIONANO GENOMICS INC | $15.47M | 10,176,000 | 0.94% | 99.06% | Net Selling | Net Selling | ||
| NKTX | NKARTA INC | $132.83M | 71,029,512 | 61.14% | 38.86% | Net Selling | |||
| AKTX | AKARI THERAPEUTICS PLC | $37.81M | 71,479,461,523 | 0.00% | 6.24% | Net Buying | Net Buying | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $154.62M | 74,337,990 | 26.50% | 73.50% | Net Buying | Net Buying | ||
| SNTI | SENTI BIOSCIENCES INC | $42.33M | 26,290,838 | 18.58% | 81.42% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.